TREC-SAVE: a trial for aggressive or violent seriously mentally ill people

ISRCTN ISRCTN49454276
DOI https://doi.org/10.1186/ISRCTN49454276
Secondary identifying numbers N/A
Submission date
14/12/2010
Registration date
04/03/2011
Last edited
28/07/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Not provided at time of registration

Contact information

Dr Gisele Huf
Scientific

Av Brasil 4365 Manguinhos
Rio de Janeiro
21040-900
Brazil

Email gisele.huf@incqs.fiocruz.br

Study information

Study designSingle-centre randomised open controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleRandomised controlled trial comparing mechanical restraints with seclusion for aggressive mentally ill people in emergency psychiatric hospitals
Study acronymTREC-SAVE
Study hypothesisThe trial aims to test the hypothesis that one procedure (seclusion or restraints) is more effective and/or more safe for the management of agitated and violent people in emergency psychiatric hospitals.
Ethics approval(s)Ethics Committee from Philippe Pinel Institute in Rio de Janeiro approved on the 24th February 2010 (ref: 56/2010)
ConditionAggressive/violent mental illness
Intervention1. Use of four point physical restraint (cotton bands) and policy of close recording of mental state, behaviour, wellbeing, in addition to standard use of medication.
2. Use of secure seclusion room and policy of close recording of mental state, behaviour, wellbeing, in addition to standard use of medication.

In the case of Instituto Philippe Pinel secure seclusion involves a locked room with minimal bedding but airy and with good day light though barred windows with no frame or glass open to the nursing station or passing patients.

The total duration of each intervention is exactly the primary outcome, but follow-up in each arm will last by two weeks.
Intervention typeOther
Primary outcome measureTime to release from restraints or seclusion
Secondary outcome measures1. Safe resolution of episode, measured 24 hours after the beginning of the episode
2. Time in restriction, measured 24 hours after the beginning of the episode
3. Further episode, measured 24 hours after the beginning of the episode
4. Need to call the doctor on an emergency basis, measured 24 hours after the beginning of the episode
5. Refusal of oral medication, measured 24 hours after the beginning of the episode
6. Amount of medication and how administered, measured 24 hours after the beginning of the episode
7. Acceptability to patient/staff, measured 24 hours after the beginning of the episode
8. Adverse effects, measured at 2 weeks
9. Time to discharge, measured at 2 weeks
Overall study start date16/06/2010
Overall study end date30/04/2011

Eligibility

Participant type(s)Patient
Age groupOther
SexBoth
Target number of participants100 people
Participant inclusion criteria1. Anyone (no age or gender limits) thought to have a serious mental illness admitted to the hospital who has a degree or risk of aggression or violent behaviour that endangers themselves or others
2. Who is thought by medical and nursing staff to need some form of physical restriction
3. For whom the medical and nursing staff have doubt as to whether one form of restriction is better than the other
Participant exclusion criteria1. Anyone for whom either or both packages of care are contraindicated by either medical or nursing staff
2. Anyone already randomised in this trial
Recruitment start date16/06/2010
Recruitment end date30/04/2011

Locations

Countries of recruitment

  • Brazil

Study participating centre

Av Brasil 4365 Manguinhos
Rio de Janeiro
21040-900
Brazil

Sponsor information

National Institute of Quality Control in Health (Brazil)
Government

Av. Brasil 4365 Manguinhos
Rio de Janeiro
21040-900
Brazil

Phone +55(0) 21 3865 5112
Email gisele.huf@incqs.fiocruz.br
Website http://www.incqs.fiocruz.br
ROR logo "ROR" https://ror.org/04jhswv08

Funders

Funder type

Research organisation

National Institute of Quality Control in Health - Oswaldo Cruz Foundation (Brazil)

No information available

Federal University of Rio de Janeiro (UFRJ) (Brazil) - School of medicine

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 20/07/2011 Yes No